Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Neoral Oral Solution 50 Ml By Novartis Pharma

Image 0 of Neoral Oral Solution 50 Ml By Novartis PharmaImage 1 of Neoral Oral Solution 50 Ml By Novartis Pharma

Neoral Oral Solution 50 Ml By Novartis Pharma

Call for Price

Neoral Oral Solution 50 Ml By Novartis Pharma This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXD2378628/RXB10026121
Size : 50 ML
Selling UoM : EA
NDC: 00078-0274-22
UPC Barcode : 000780274226
Supplier: 0050001965 NOVARTIS PHARM CORP
Supplier Material : 027422
Generic Code : 023883 CYCLOSPORINE, MODIFIED ORAL SOLUTION 100
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product Type : BRX Branded RX

Have a question?

  Call for Price

Product Description.:

Solution , clear , yellow

WARNING

Only physicians experienced in management of systemic immunosuppressive therapy for the indicated disease should prescribe Neoral?. At doses used in solid organ transplantation, only physicians experienced in immunosuppressive therapy and management of organ transplant recipients should prescribe Neoral?. Patients receiving the drug should be managed in facilities equipped and staffed with adequate laboratory and supportive medical resources. The physician responsible for maintenance therapy should have complete information requisite for the follow-up of the patient.

Neoral?, a systemic immunosuppressant, may increase the susceptibility to infection and the development of neoplasia. In kidney, liver, and heart transplant patients Neoral? may be administered with other immunosuppressive agents. Increased susceptibility to infection and the possible development of lymphoma and other neoplasms may result from the increase in the degree of immunosuppression in transplant patients.

Neoral? Soft Gelatin Capsules (cyclosporine capsules, USP) MODIFIED and Neoral? Oral Solution (cyclosporine oral solution, USP) MODIFIED have increased bioavailability in comparison to Sandimmune? Soft Gelatin Capsules (cyclosporine capsules, USP) and Sandimmune? Oral Solution (cyclosporine oral solution, USP). Neoral? and Sandimmune? are not bioequivalent and cannot be used interchangeably without physician supervision. For a given trough concentration, cyclosporine exposure will be greater with Neoral? than with Sandimmune?. If a patient who is receiving exceptionally high doses of Sandimmune? is converted to Neoral?, particular caution should be exercised. Cyclosporine blood concentrations should be monitored in transplant and rheumatoid arthritis patients taking Neoral? to avoid toxicity due to high concentrations. Dose adjustments should be made in transplant patients to minimize possible organ rejection due to low concentrations. Comparison of blood concentrations in the published literature with blood concentrations obtained using current assays must be done with detailed knowledge of the assay methods employed.

For Psoriasis Patients (See also Boxed WARNINGS above)

Psoriasis patients previously treated with PUVA and to a lesser extent, methotrexate or other immunosuppressive agents, UVB, coal tar, or radiation therapy, are at an increased risk of developing skin malignancies when taking Neoral?.

Cyclosporine, the active ingredient in Neoral?, in recommended dosages, can cause systemic hypertension and nephrotoxicity. The risk increases with increasing dose and duration of cyclosporine therapy. Renal dysfunction, including structural kidney damage, is a potential consequence of cyclosporine, and therefore, renal function must be monitored during therapy.
DRUG DESCRIPTION

Neoral? is an oral formulation of cyclosporine that immediately forms a microemulsion in an aqueous environment.

Cyclosporine, the active principle in Neoral?, is a cyclic polypeptide immunosuppressant agent consisting of 11 amino acids. It is produced as a metabolite by the fungus species Beauveria nivea.

Neoral? Soft Gelatin Capsules

(cyclosporine) Capsules, USP MODIFIED are available in 25 mg and 100 mg strengths.

Each 25 mg capsule contains:

cyclosporine.............................................................25 mg
alcohol, USP dehydrated.............................................................11.9% v/v (9.5% wt/vol.)

Each 100 mg capsule contains:

cyclosporine.............................................................100 mg
alcohol, USP dehydrated.............................................................11.9% v/v (9.5% wt/vol.)

Inactive Ingredients: Corn oil-mono-di-triglycerides, polyoxyl 40 hydrogenated castor oil NF, DL-α tocopherol USP, gelatin NF, glycerol, iron oxide black, propylene glycol USP, titanium dioxide USP, carmine, and other ingredients.

Neoral? Oral Solution

(cyclosporine) Oral Solution, USP MODIFIED is available in 50 mL bottles.

Each mL contains:

cyclosporine......................................100 mg/mL
alcohol, USP dehydrated...............................11.9% v/v (9.5% wt/vol.)

Inactive Ingredients: Corn oil-mono-di-triglycerides, polyoxyl 40 hydrogenated castor oil NF, DL-α tocopherol USP, propylene glycol USP.

INDICATIONS
Kidney, Liver, and Heart Transplantation

Neoral? is indicated for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. Neoral? has been used in combination with azathioprine and corticosteroids.
Rheumatoid Arthritis

Neoral? is indicated for the treatment of patients with severe active, rheumatoid arthritis where the disease has not adequately responded to methotrexate. Neoral? can be used in combination with methotrexate in rheumato